ArticleScientific reports2026
Breed-specific innate immune responses to Brucella abortus strain RB51 and Bacillus Calmette-Guérin in cattle.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Bovine brucellosis and bovine tuberculosis are chronic diseases that cause economic and animal health concerns in the global beef and dairy industries due to production losses. The etiologic agents of these diseases, Brucella abortus and Mycobacterium bovis, are intracellular, zoonotic bacterial pathogens that pose a risk to human health. Brucella abortus strain RB51 (RB51) and Bacillus Calmette-Guérin (BCG) are live attenuated vaccines for bovine brucellosis and tuberculosis, respectively, and are known to reduce incidence of these diseases in cattle. However, recent work has suggested that the genetic background of cattle may influence immune responses to these two vaccines. Control of brucellosis and tuberculosis depends on T helper 1 (Th1) mediated immune responses; however, both RB51 and BCG are intracellular bacteria that predominantly localize in monocytes and macrophages which are responsible for initiating immune responses to disease. This study investigates the difference in responses of Hereford and Holstein monocyte-enriched peripheral blood mononuclear cells infected in vitro with RB51, BCG, and combined RB51 + BCG. Transcriptomic data was collected to conduct a targeted evaluation of differentially expressed genes between cell conditions from Holsteins and Herefords related to innate immune responses against intracellular bacteria and the downstream generation of adaptive immune responses. Additionally, breed-specific differences in the production of pro-inflammatory, anti-inflammatory, and Th1-related cytokines by infected monocyte-enriched cells were evaluated. After 16 h of infection with RB51, BCG, or RB51 + BCG, monocyte-enriched cells from Holsteins displayed a transcriptomic profile consistent with enhanced pro-inflammatory and Th1-polarizing responses compared to infected cells from Herefords. Further, Holstein cells also produced significantly higher amounts of Th1-polarizing cytokine than Hereford cells after 72 h of intracellular infection. The breed-specific differences in cellular responses presented here following in vitro infection with RB51, BCG, and RB51 + BCG provide evidence that Hereford and Holstein cattle may develop variable immune responses in vivo to these two vaccines. Results of this study suggest that vaccine efficacy may be influenced by cattle host genetic background within the same species and thus warrants consideration when optimizing vaccination strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.